 |
市場調查報告書
商品編碼
1550765
全球醋酸環丙孕酮市場：按劑型、應用、地區Cyproterone Acetate Market, By Formulation, By Application, By Geography |
||||||
價格
簡介目錄
預計2024年全球醋酸環丙孕酮市場規模為3.271億美元，預計2031年將達4.451億美元，2024年至2031年複合年成長率為4.5%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 3.271 億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 4.50% | 2031年價值預測 | 4.451 億美元 |
圖：2024 年按地區分類的醋酸環丙孕酮市場佔有率(%)
醋酸環丙孕酮 (CPA) 是一種黃體素和抗雄性激素類固醇藥物，主要用於治療前列腺癌、早熟症、痤瘡和女性毛髮過度生長。它作為黃體酮促效劑或拮抗劑，並通過與雄激素受體競爭作為抗雄激素。 CPA是臨床上最早使用的抗雄性激素藥物之一，至今仍是臨床使用的重要藥物。它在世界各地以多種品牌出售，包括單獨銷售和與雌激素聯合銷售。
市場動態：
全球醋酸環丙孕酮市場受到男性前列腺癌發病率上升以及女性痤瘡和多毛症病例增加的推動。此外，生活方式的改變和老年人口的增加是推動市場成長的主要因素。然而，長期使用醋酸環丙孕酮的副作用，如肝毒性、疲勞和憂鬱症，以及替代藥物的出現，預計將在一定程度上阻礙市場擴張。開發具有改進安全性的共軛 CPA 可能會在預測期內創造利潤豐厚的機會。
本研究的主要特點
- 本報告對全球醋酸環丙孕酮市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
- 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
- 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球醋酸環丙孕酮市場的主要企業概況。
- 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 醋酸環丙孕酮全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球醋酸環丙孕酮市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購場景
第4章全球醋酸環丙孕酮市場：依配方分類（2024-2031）
- 錠劑
- 注射
- 局部製劑
第5章全球醋酸環丙孕酮市場：依應用分類（2024-2031）
- 荷爾蒙補充療法
- 避孕
- 痤瘡治療
- 其他
第6章全球醋酸環丙孕酮市場：按地區（2019-2031）
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第7章 競爭格局
- Curia
- Axplora
- LGM Pharma
- Hubei Gedian Humanwell Pharmaceutical
- Cipla
- NEWCHEM SPA
- Swati Spentose
- Teva API
- Teva Pharmaceutical Industries
- Unipex
- Zhejiang Xianju Pharmaceutical Co. Ltd
- KRKA
- Cambrex
- Sicor De Mexico
- Zhejiang Xianju Xianle
- Shaoxing Hantai Pharma
- Farmabios
第8章 分析師建議
- Wheel of Fortune
- 分析師觀點
- Coherent Opportunity Map（COM）
第9章 參考文獻及調查方法
- 參考
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI7287
The global cyproterone acetate market is estimated to be valued at USD 327.1 Mn in 2024 and is expected to reach USD 445.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 327.1 Mn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 4.50% | 2031 Value Projection: | US$ 445.1 Mn |
Figure. Cyproterone Acetate Market Share (%), By Region 2024
Cyproterone acetate (CPA) is a progestogen and antiandrogen steroid medication that is used primarily in the treatment of prostate cancer, precocious puberty, acne, and excessive hair growth in women. It acts as a progesterone agonist or antagonist and as an antiandrogen by competing for the androgen receptor. CPA was one of the earliest clinically used antiandrogens and remains an important medication in clinical use today. It is available both as a standalone medication and in combination with an estrogen under various brand names throughout the world.
Market Dynamics:
The global cyproterone acetate market is driven by the increasing incidence of prostate cancer in men, and rising cases of acne and hirsutism in women. Moreover, shifting lifestyle patterns and growing geriatric population are major factors fueling the market growth. However, side effects associated with the long-term use of cyproterone acetate such as liver toxicity, fatigue, and depression along with the availability of alternative medications are expected to hamper market expansion to some extent. The development of conjugated forms of CPA with improved safety profiles can create lucrative opportunities over the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global cyproterone acetate market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cyproterone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Curia, Axplora, LGM Pharma, Hubei Gedian Humanwell Pharmaceutical, Cipla, NEWCHEM SPA, Swati Spentose, Teva API, Teva Pharmaceutical Industries, Unipex, Zhejiang Xianju Pharmaceutical Co. Ltd, KRKA, Cambrex, Sicor De Mexico, Zhejiang Xianju Xianle, Shaoxing Hantai Pharma, and Farmabios
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cyproterone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cyproterone acetate market
Detailed Segmentation:
- Formulation Insights (Revenue, USD Mn, 2019 - 2031)
- Tablets
- Injectables
- Topical Preparations
- Application Insights (Revenue, USD Mn, 2019 - 2031)
- Hormonal Replacement Therapy
- Contraception
- Acne Treatment
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Curia
- Axplora
- LGM Pharma
- Hubei Gedian Humanwell Pharmaceutical
- Cipla
- NEWCHEM SPA
- Swati Spentose
- Teva API
- Teva Pharmaceutical Industries
- Unipex
- Zhejiang Xianju Pharmaceutical Co. Ltd
- KRKA
- Cambrex
- Sicor De Mexico
- Zhejiang Xianju Xianle
- Shaoxing Hantai Pharma
- Farmabios
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cyproterone Acetate Market, By Formulation
- Global Cyproterone Acetate Market, By Application
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Cyproterone Acetate Market, By Formulation, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Topical Preparations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Cyproterone Acetate Market, By Application, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hormonal Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Contraception
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Acne Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Cyproterone Acetate Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Formulation , 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
7. COMPETITIVE LANDSCAPE
- Curia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Axplora
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LGM Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hubei Gedian Humanwell Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NEWCHEM SPA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Swati Spentose
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva API
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Unipex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zhejiang Xianju Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KRKA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cambrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sicor De Mexico
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zhejiang Xianju Xianle
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shaoxing Hantai Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Farmabios
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us
